You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Hybrid CMOS/Nanodevice Integrated Circuits

    SBC: Sensor Electronic Technology, Inc.            Topic: AF07T025

    We propose to develop a novel hybrid circuit approach combining CMOS and two terminal crosspoint nanodevices with a novel interface consisting of an array of pins with nanometer scale tips. Our CMOL approach will allow the fabrication of ultra-dense integrated circuits (up to 10^12 active devices per cm2) for advanced computing (up to 10^20 operation per cm2 per second), information storage and se ...

    STTR Phase II 2009 Department of DefenseAir Force
  2. Restoration of Skin Structure and Function Post-Wounding

    SBC: FirstString Research, Inc            Topic: N/A

    DESCRIPTION (provided by applicant): The wound repair process in skin is initiated immediately after an injury and induces a cascade of events including inflammation, proliferation, and scar differentiation. The adverse changes in skin structure and function resulting from scar tissue affects over 35 million US citizens a year resulting in costs of more than 7 billion dollars). The founders of Fir ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  3. Nanotailored Carbon Fibers

    SBC: NANO ENGINEERED MATERIALS CORP.            Topic: AF08T028

    Polyacrylonitrile (PAN)/carbon nanotube (CNT) composite fibers will be spun using gel spinning technology in conjunction with bi-component spinning to obtain small diameter precursor fiber (2 - 6 micrometer). Single component spinning (multi-filaments) will also be conducted. The precursor fibers will have tensile strength >1 GPa and tensile modulus >25 GPa. By optimizing stabilization and carboni ...

    STTR Phase II 2010 Department of DefenseAir Force
  4. High Expression Recombinant Factor VIII

    SBC: EXPRESSION THERAPEUTICS, LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): The hemophilias (A and B) are rare bleeding disorders toward which much scientific and medical effort has been devoted. In 1840, blood transfusion was used for the first time to stop post-operative bleeding in a hemophilia patient and in 1968 the first commercial coagulation factor concentrate became available. The cloning of the fVIII gene in 1984 facilitated ...

    STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health
  5. Electrical power generation for sustained high speed flight

    SBC: Johnson Research & Development Co Inc            Topic: AF08BT25

    ABSTRACT: Providing electrical power for long duration hypersonic flight is a technology that is required to bring about this revolutionary mode of transport. Whether for weapons delivery or for space access, the long duration missions anticipated require a novel approach to the generation of electrical power during flight. Scramjets contain no rotating shafts from which typical generators or mec ...

    STTR Phase II 2011 Department of DefenseAir Force
  6. Continuous monitoring of anti-fibrinolytic therapy in cardiovascular surgery

    SBC: Micro Vide, LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): A major cause of morbidity and mortality in cardiovascular surgery is excessive bleeding post- operatively, which is commonly managed by pharmacologically modifying clot degradation (fibrinolysis), through inhibition of plasmin activity (PLact). However, the only FDA approved and most commonly used inhibitor of PLact in cardiovascular surgery, while effective i ...

    STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  7. Dynamic facial soft tissue analysis system.

    SBC: 3DMD, LLC            Topic: NIDCR

    DESCRIPTION (provided by applicant): The primary goal of this Phase II STTR application is to complete the development of a landmark-free quantitative 4D facial analysis system for static analyses (completed in Phase I) and dynamic analyses of soft tissuemovement (planned for Phase II). The potential target applications are wide-ranging-facial recognition for identification simulation for training ...

    STTR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  8. Novel WEB Decision Support System for cardiac image interpretation and reporting

    SBC: SYNTERMED INCORPORATED            Topic: NHLBI

    DESCRIPTION (provided by applicant): Today's cardiac imaging field requires diagnosticians to master an ever-expanding knowledge base (KB) while the time to master this knowledge, apply it to specific tasks and reimbursement are steadily shrinking. These constraints pose a serious healthcare problem that inevitably leads to physician's errors. Thus new tools are required to assist physic ...

    STTR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health
  9. Precise fabrication of integrated photonic and optoelectronic systems using low-cost nanoimprint process

    SBC: Sinoora Inc.            Topic: OSD10T006

    There are major technical and financial barriers that are preventing Si photonics and optoelectronics to transition from R & D to commercial product domain. The main technical challenge is the nanometric scale precision required for proper functioning of Si photonic devices. High index contrast of Si with its cladding materials allows reducing the size of photonic elements and hence allows packing ...

    STTR Phase II 2013 Department of DefenseAir Force
  10. High-specificity affinity reagents for N-glycosylation site mapping and glycomics

    SBC: GLYCOSENSORS AND DIAGNOSTICS, LLC            Topic: NIGMS

    DESCRIPTION: Glycans have several distinct properties that make them excellent targets for disease biomarkers. Firstly, the location of the glycans on the cell surface makes them the first point of contact of cellular interactions and thus crucial in thecontrol of normal metabolic processes. Cell surface molecules are also strategically exposed for surveillance by the immune system allowing for t ...

    STTR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government